BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3232956)

  • 1. Biological activity of serum prolactin in patients with primary hypothyroidism.
    Smith CR; Butler J; Norman MR
    Ann Clin Biochem; 1988 Sep; 25 ( Pt 5)():540-5. PubMed ID: 3232956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of Nb2 bioassay and radioimmunoassay values for human serum prolactin.
    Rowe RC; Cowden EA; Faiman C; Friesen HG
    J Clin Endocrinol Metab; 1983 Nov; 57(5):942-6. PubMed ID: 6413527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum prolactin bioactivity and immunoactivity in hyperprolactinaemic states.
    Smith CR; Butler J; Hashim I; Norman MR
    Ann Clin Biochem; 1990 Jan; 27 ( Pt 1)():3-8. PubMed ID: 2310154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum prolactin in uraemia: correlations between bioactivity and activity in two immunoassays.
    Smith CR; Butler J; Iggo N; Norman MR
    Acta Endocrinol (Copenh); 1989 Mar; 120(3):295-300. PubMed ID: 2929235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new microbioassay for the measurement of lactogenic hormones in human serum.
    Maddox PR; Jones DL; Mansel RE
    Horm Res; 1989; 32(5-6):218-23. PubMed ID: 2634615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of biological activity of prolactin molecular weight variants in human sera.
    Whitaker MD; Klee GG; Kao PC; Randall RV; Heser DW
    J Clin Endocrinol Metab; 1984 May; 58(5):826-30. PubMed ID: 6707188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rat lymphoma cell bioassay for prolactin: observations on its use and comparison with radioimmunoassay.
    Lawson DM; Sensui N; Haisenleder DH; Gala RR
    Life Sci; 1982 Dec; 31(26):3063-70. PubMed ID: 7162366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum specifically potentiates the mitogenic response of Nb2 lymphoma cells to rat prolactin.
    Moy JA; Lawson DM
    Endocrinology; 1988 Sep; 123(3):1314-9. PubMed ID: 3402387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin deficiency in rheumatoid arthritis.
    Nagy E; Chalmers IM; Baragar FD; Friesen HG; Berczi I
    J Rheumatol; 1991 Nov; 18(11):1662-8. PubMed ID: 1787486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation and comparison of Nb2 lymphoma cell bioassay with radioimmunoassay for human prolactin.
    Subramanian MG; Spirtos NJ; Moghissi KS; Magyar DM; Hayes MF; Gala RR
    Fertil Steril; 1984 Dec; 42(6):870-4. PubMed ID: 6500079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-prolactin (PRL) autoantibodies suppress PRL bioactivity in patients with macroprolactinaemia.
    Hattori N; Nakayama Y; Kitagawa K; Ishihara T; Saiki Y; Inagaki C
    Clin Endocrinol (Oxf); 2008 Jan; 68(1):72-6. PubMed ID: 17681026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum prolactin and growth hormone determined by radioimmunoassay and a two-site immunoradiometric assay: comparison with the Nb2 cell bioassay.
    Rose DP; Berke B; Cohen LA
    Horm Metab Res; 1988 Jan; 20(1):49-53. PubMed ID: 3371857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human macroprolactin displays low biological activity via its homologous receptor in a new sensitive bioassay.
    Glezer A; Soares CR; Vieira JG; Giannella-Neto D; Ribela MT; Goffin V; Bronstein MD
    J Clin Endocrinol Metab; 2006 Mar; 91(3):1048-55. PubMed ID: 16384849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cysteamine on pituitary, MTTW15 tumor, and serum prolactin levels measured by rat lymphoma cell bioassay and radioimmunoassay.
    Parsons JA; Peterson EK; Hartfel MA
    Endocrinology; 1984 May; 114(5):1812-7. PubMed ID: 6714167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quantitative difference between immunologically and biologically active prolactin in hypothyroid patients.
    Silverman AY; Schwartz SL; Steger RW
    J Clin Endocrinol Metab; 1982 Aug; 55(2):272-5. PubMed ID: 7085855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between bioactivity and immunoreactivity of serum prolactin in uraemia.
    Mooradian AD; Morley JE; Korchik WP; Ma KW; Hartfel MA; Parsons JA
    Clin Endocrinol (Oxf); 1985 Mar; 22(3):241-7. PubMed ID: 3978831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular heterogeneity of prolactin in the plasma of patients with systemic lupus erythematosus.
    Cruz J; Aviña-Zubieta A; Martínez de la Escalera G; Clapp C; Lavalle C
    Arthritis Rheum; 2001 Jun; 44(6):1331-5. PubMed ID: 11407692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrinsic bioactivity of thyrotropin in human serum is inversely correlated with thyroid hormone concentrations. Application of a new bioassay using the FRTL-5 rat thyroid cell strain.
    Dahlberg PA; Petrick PA; Nissim M; Menezes-Ferreira MM; Weintraub BD
    J Clin Invest; 1987 May; 79(5):1388-94. PubMed ID: 3571493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of new homologous in vitro bioassays for human lactogens to assess the actual bioactivity of human prolactin isoforms in hyperprolactinaemic patients.
    Leaños-Miranda A; Cárdenas-Mondragón G; Rivera-Leaños R; Ulloa-Aguirre A; Goffin V
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):146-53. PubMed ID: 16886952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proliferative effect of prolactin and growth hormone from human serum in cultured rat lymphoma Nb2 cells].
    Bulatov AA; Osipova TA; Raevskaia GV
    Biull Eksp Biol Med; 1996 Nov; 122(11):559-63. PubMed ID: 8998352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.